David P. Schenkein, Chief Executive Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 92,816 shares at $80.01 ($7.4M) on 2018-01-24, disclosed to the SEC on 2018-01-25.
Open-market sale of $7.4M AGIO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.01 | 32,875 | $2.6M | 35.4% |
| 2 | $80.01 | 32,875 | $2.6M | 35.4% |
| 3 | $80.01 | 13,533 | $1.1M | 14.6% |
| 4 | $80.01 | 13,533 | $1.1M | 14.6% |
| Total | $80.01 avg | 92,816 | $7.4M | 100% |
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |